8 12, 2016 Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications Diatech Pharmacogenetics2016-12-08T17:27:27+01:00 Read More
27 11, 2016 Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs Diatech Pharmacogenetics2016-11-27T09:58:58+01:00 Read More
25 11, 2016 Laura Capelli et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports Diatech Pharmacogenetics2017-08-08T12:52:59+02:00 Read More
8 11, 2016 Federico Pessina et al., Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology Diatech Pharmacogenetics2016-11-08T10:06:17+01:00 Read More
11 10, 2016 Annarita Destro et al., The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology Diatech Pharmacogenetics2017-08-07T16:00:55+02:00 Read More
1 10, 2016 Véronique Quilien et al., P06.13?A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab. Neuro Oncology Diatech Pharmacogenetics2016-10-01T16:21:08+02:00 Read More
1 10, 2016 Marie Duhamel et al., P06.11 Classification of high-grade glioma using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry imaging (MALDI MSI): interim results of the GLIOMIC study. Neuro Oncology Diatech Pharmacogenetics2017-12-04T14:36:51+01:00 Read More
22 09, 2016 Andrea Botticelli et al., Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker? PLOS One Diatech Pharmacogenetics2017-08-08T12:45:17+02:00 Read More
31 08, 2016 Giuseppe Aprile et al., Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology Diatech Pharmacogenetics2016-08-31T11:25:22+02:00 Read More
21 08, 2016 Roberto Moretto et al., Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist Diatech Pharmacogenetics2016-08-21T11:46:30+02:00 Read More
